Based on 2 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$28.00
+50.9% upside
Average target across 2 active firms as of Nov 19, 2026 vs $18.55 current
Highest Target$28.00
Average Target$28.00
Lowest Target$28.00
Detailed analyst forecasts for NX
Showing 1–1 of 1 named analysts shown · 2 active firms in the rating projection
Analyst Rating
Upside / Downside
Action
ANALYST
FIRM
PRICE TARGET
RATING
UPSIDE
ACTION
DATE
RGReuben Garner
SStoneX
$28.00
Buy
+50.9%
Reiterates
09/10/26
NX analyst recommendation trends
86420
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Strong BuyBuyNeutralSellStrong Sell
RATING
JUN
JUL
AUG
SEP
OCT
NOV
Strong Buy
0
0
0
0
0
0
Buy
1
1
1
2
2
2
Neutral
0
0
0
0
0
0
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
1
1
1
2
2
2
As of Nov 19, 2026, 2 of 2 active firms rate NX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.04
Range $-0.19 – $0.07 · 4 analysts · +350% YoY
Next period, 4 analysts expect Quanex Building Products to earn $-0.04 a share (range $-0.19 – $0.07), versus $-0.01 a year earlier. Full-year consensus is $1.80, growing to $1.90 the year after.
REVENUE · NEXT QUARTER
$407.4M
Range $406.6M – $408.0M · 4 analysts · -0% YoY
Revenue is expected to reach $407.4M (range $406.6M – $408.0M), -0.4% year-over-year., rising to $1.9B next year.
Top analysts covering Quanex Building Products
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NX.
#1
Reuben Garner
Benchmark · Rank #436
Buy
$28.00+50.9% to target
Overall win rate
32%
+ Follow
#2
AT
Adam Thalhimer
Thompson Davis
Buy
$30.00+61.7% to target
Coverage
—
+ Follow
NX stock forecast FAQ
What is NX's average 12-month price target?+
The 2 active firms with a live target average $28.00 for Quanex Building Products over the next 12 months, ranging from a $28.00 high to a $28.00 low, as of Nov 19, 2026.
Is NX stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover NX?+
2 active firms have a recognized rating on Quanex Building Products as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NX?+
Among analysts who currently cover NX, Reuben Garner of Benchmark has the strongest overall Quantellect track record (Rank #436). Their current call is Buy with a $28.00 target.
What is Quanex Building Products's projected EPS for next quarter?+
The consensus estimate is $-0.04 per share (range $-0.19 – $0.07) across 4 analysts. Full-year EPS is projected at $1.80, rising to $1.90 the following year.
How much revenue is Quanex Building Products expected to report next quarter?+
Consensus revenue is $407.4M (range $406.6M – $408.0M). Full-year revenue is projected at —, growing to $1.9B next year.
Have analysts been upgrading or downgrading NX lately?+
As of Nov 19, 2026, 2 of 2 active firms rate NX a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.